Search

everythinglearnresearchcommunity

for

Search:↓

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Pioglitazone may help treat lichen planopilaris, but more research is needed.

The diphosphonate was the most effective at preventing calcification in rats.

Dapagliflozin improved blood sugar control in a man with Werner syndrome without side effects.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Changing the 6-position on benzopyran molecules affects insulin release, with some compounds showing strong inhibitory effects.

Diphencyprone initially increases mouse hair growth, then slows it, possibly due to changes in specific protein levels.

Diphencyprone can cause unexpected and possibly permanent vitiligo.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

GLP-1 receptor analogs may help improve metabolism and reproductive health in people with PCOS and obesity.

Dapagliflozin helps protect heart cells under stress by improving mitochondrial function and reducing cell damage.

More research is needed to understand if GLP-1 agonists affect hair health.

Upadacitinib may effectively treat resistant lichen planopilaris.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

RSPO1 could help create new diabetes treatments by increasing pancreatic β cells.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

Dutasteride may help protect neurons and reduce inflammation in Parkinson's disease.

Finasteride reduces movement issues in Parkinson's disease rats.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Two peptides, RMYYY and VMYMI, may be effective anti-inflammatory drugs.

Higher SFRP-4 levels were found in people without a diabetic family history.

Pegylated interferon-alpha 2a can cause a rare nerve disorder, but early treatment can lead to full recovery.

GLP-1 receptor agonists help with weight loss but need to be combined with other treatments for best results.